Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

TherapeuticsMD Retained Earnings (Accumulated Deficit) 2012-2024 | TXMD

TherapeuticsMD retained earnings (accumulated deficit) from 2012 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  
TherapeuticsMD Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-950
2022 $-939
2021 $-1,051
2020 $-879
2019 $-695
2018 $-519
2017 $-387
2016 $-310
2015 $-220
2014 $-135
2013 $-81
2012 $-52
2011 $-17
TherapeuticsMD Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-06-30 $-951
2024-03-31 $-950
2023-12-31 $-950
2023-09-30 $-949
2023-06-30 $-945
2023-03-31 $-943
2022-12-31 $-939
2022-09-30 $-1,017
2022-06-30 $-988
2022-03-31 $-1,100
2021-12-31 $-1,051
2021-09-30 $-1,008
2021-06-30 $-961
2021-03-31 $-918
2020-12-31 $-879
2020-09-30 $-837
2020-06-30 $-804
2020-03-31 $-752
2019-12-31 $-695
2019-09-30 $-646
2019-06-30 $-614
2019-03-31 $-559
2018-12-31 $-519
2018-09-30 $-480
2018-06-30 $-444
2018-03-31 $-411
2017-12-31 $-387
2017-09-30 $-365
2017-06-30 $-351
2017-03-31 $-331
2016-12-31 $-310
2016-09-30 $-287
2016-06-30 $-262
2016-03-31 $-241
2015-12-31 $-220
2015-09-30 $-202
2015-06-30 $-183
2015-03-31 $-156
2014-12-31 $-135
2014-09-30 $-118
2014-06-30 $-101
2014-03-31 $-90
2013-12-31 $-81
2013-09-30 $-72
2013-06-30 $-64
2013-03-31 $-58
2012-12-31 $-52
2012-09-30 $-46
2012-06-30 $-42
2012-03-31 $-30
2011-12-31 $-17
2011-09-30
2011-06-30
2011-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.020B $0.001B
TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $88.667B 35.33
Takeda Pharmaceutical (TAK) Japan $47.251B 9.46
Merck (MKGAF) Germany $23.748B 25.92
Astellas Pharma (ALPMY) Japan $21.535B 25.87
Summit Therapeutics (SMMT) United States $18.997B 0.00
Sandoz Group AG (SDZNY) Switzerland $17.531B 0.00
United Therapeutics (UTHR) United States $15.350B 15.86
Shionogi (SGIOY) Japan $13.285B 12.73
Neurocrine Biosciences (NBIX) United States $12.350B 36.95
Catalent (CTLT) United States $10.951B 0.00
Orion OYJ (ORINY) Finland $7.373B 30.02
Revolution Medicines (RVMD) United States $7.311B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.889B 7.31
Ionis Pharmaceuticals (IONS) United States $6.069B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.067B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.241B 0.00
Corcept Therapeutics (CORT) United States $4.149B 35.14
Dyne Therapeutics (DYN) United States $3.474B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.733B 15.77
PTC Therapeutics (PTCT) United States $2.698B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.488B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.426B 19.28
Soleno Therapeutics (SLNO) United States $2.057B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.900B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.845B 0.00
Xencor (XNCR) United States $1.640B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.639B 0.00
Harrow (HROW) United States $1.546B 0.00
Cassava Sciences (SAVA) United States $1.502B 0.00
Ardelyx (ARDX) United States $1.448B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.391B 0.00
Ocular Therapeutix (OCUL) United States $1.366B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.331B 0.00
Indivior (INDV) United States $1.311B 6.02
Evotec AG (EVO) Germany $1.290B 0.00
ARS Pharmaceuticals (SPRY) United States $1.265B 0.00
Collegium Pharmaceutical (COLL) United States $1.204B 6.91
Calliditas Therapeutics AB (CALT) Sweden $1.199B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.021B 0.00
Relay Therapeutics (RLAY) United States $1.018B 0.00
Enliven Therapeutics (ELVN) United States $1.014B 0.00
Bioventus (BVS) United States $0.921B 29.92
Cronos Group (CRON) Canada $0.864B 0.00
4D Molecular Therapeutics (FDMT) United States $0.840B 0.00
USANA Health Sciences (USNA) United States $0.761B 13.97
Savara (SVRA) United States $0.729B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.716B 44.80
ProKidney (PROK) United States $0.692B 0.00
Pacira BioSciences (PCRX) United States $0.662B 6.26
Corbus Pharmaceuticals Holdings (CRBP) United States $0.613B 0.00
Exscientia (EXAI) United Kingdom $0.608B 0.00
Siga Technologies (SIGA) United States $0.562B 6.74
Silence Therapeutics (SLN) United Kingdom $0.546B 0.00
Foghorn Therapeutics (FHTX) United States $0.544B 0.00
OmniAb (OABI) United States $0.541B 0.00
Altimmune (ALT) United States $0.538B 0.00
Eliem Therapeutics (ELYM) United States $0.534B 0.00
Tourmaline Bio (TRML) United States $0.496B 0.00
Sage Therapeutics (SAGE) United States $0.459B 0.00
KalVista Pharmaceuticals (KALV) United States $0.457B 0.00
Verve Therapeutics (VERV) United States $0.456B 0.00
Aquestive Therapeutics (AQST) United States $0.436B 0.00
Larimar Therapeutics (LRMR) United States $0.435B 0.00
Xeris Biopharma Holdings (XERS) United States $0.432B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 38.25
Theravance Biopharma (TBPH) Cayman Islands $0.403B 0.00
Zevra Therapeutics (ZVRA) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.386B 0.00
Lyell Immunopharma (LYEL) United States $0.356B 0.00
Esperion Therapeutics (ESPR) United States $0.349B 0.00
Korro Bio (KRRO) United States $0.347B 0.00
Aldeyra Therapeutics (ALDX) United States $0.343B 0.00
Lexeo Therapeutics (LXEO) United States $0.316B 0.00
ESSA Pharma (EPIX) Canada $0.300B 0.00
Heron Therapeutics (HRTX) United States $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.288B 0.00
Black Diamond Therapeutics (BDTX) United States $0.273B 0.00
Avita Medical (RCEL) United States $0.267B 0.00
Nature's Sunshine Products (NATR) United States $0.254B 17.35
Enanta Pharmaceuticals (ENTA) United States $0.247B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.241B 0.00
Nektar Therapeutics (NKTR) United States $0.239B 0.00
Nanobiotix S.A (NBTX) France $0.236B 0.00
Acrivon Therapeutics (ACRV) United States $0.235B 0.00
Pyxis Oncology (PYXS) United States $0.213B 0.00
CytoDyn (CYDY) United States $0.205B 0.00
MediWound (MDWD) Israel $0.200B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.188B 0.00
Innate Pharma SA (IPHYF) France $0.184B 0.00
Galectin Therapeutics (GALT) United States $0.173B 0.00
Telomir Pharmaceuticals (TELO) United States $0.166B 0.00
VAXART, INC (VXRT) United States $0.164B 0.00
Context Therapeutics (CNTX) United States $0.156B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
Cardiol Therapeutics (CRDL) Canada $0.150B 0.00
Century Therapeutics (IPSC) United States $0.141B 0.00
Prelude Therapeutics (PRLD) United States $0.135B 0.00
OptiNose (OPTN) United States $0.130B 0.00
Fractyl Health (GUTS) United States $0.128B 0.00
Assertio Holdings (ASRT) United States $0.124B 21.67
Incannex Healthcare (IXHL) Australia $0.118B 0.00
CASI Pharmaceuticals (CASI) China $0.107B 0.00
Regulus Therapeutics (RGLS) United States $0.105B 0.00
Journey Medical (DERM) United States $0.105B 0.00
Relmada Therapeutics (RLMD) United States $0.104B 0.00
Metagenomi (MGX) United States $0.103B 0.00
Karyopharm Therapeutics (KPTI) United States $0.094B 0.00
Citius Pharmaceuticals (CTXR) United States $0.091B 0.00
AlloVir (ALVR) United States $0.087B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.33
Verrica Pharmaceuticals (VRCA) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Nutriband (NTRB) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
ProPhase Labs (PRPH) United States $0.050B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.046B 0.00
Inotiv (NOTV) United States $0.046B 0.00
FibroGen (FGEN) United States $0.045B 0.00
DURECT (DRRX) United States $0.044B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Tempest Therapeutics (TPST) United States $0.038B 0.00
Protara Therapeutics (TARA) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.032B 0.00
Oruka Therapeutics (ORKA) United States $0.032B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
Surrozen (SRZN) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Minerva Neurosciences (NERV) United States $0.020B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.77
Lyra Therapeutics (LYRA) United States $0.018B 0.00
BioVie (BIVI) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Indaptus Therapeutics (INDP) United States $0.015B 0.00
Talphera (TLPH) United States $0.015B 0.00
Aptorum Group (APM) United Kingdom $0.015B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Conduit Pharmaceuticals (CDT) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.010B 0.00
Vivos Therapeutics (VVOS) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.58
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.30